Clinique Acne Solutions Cleansing Foam

Description

CLINIQUE Acne Solutions Cleansing Foam is a topical formulation designed for the management of acne. This product contains salicylic acid, a recognized acne medication, which aids in the treatment and prevention of acne breakouts. The cleansing foam is provided in a dosage form of 4.2 fluid ounces (125 mL). It is classified as STEP 1 in the CLINIQUE Acne Solutions regimen, indicating its role as an initial step in the acne treatment process.

Uses and Indications

This drug is indicated for the treatment of acne. There are no teratogenic effects associated with its use, and no nonteratogenic effects have been reported.

Dosage and Administration

The recommended dosage involves using the pump dispenser to dispense 2 to 3 pumps of the product. The healthcare professional should instruct the patient to massage the product gently over wet skin, taking care to avoid the eye area. After application, the patient should rinse the skin thoroughly.

Following the cleansing step, it is advised to apply Acne Solutions Clarifying Lotion to enhance treatment efficacy. If the patient experiences bothersome drying or peeling, the frequency of use should be reduced to every other day.

To minimize the risk of excessive skin drying, it is recommended that patients start with one application daily. Based on individual tolerance and as directed by a healthcare provider, the frequency may be gradually increased to twice daily if necessary.

Once acne lesions have cleared, continued use of the product is recommended for preventative care.

Contraindications

There are no specific contraindications listed for this product. However, it is imperative to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to avoid concurrent use of this product with other topical acne medications, as this may increase the risk of skin irritation and dryness. In the event that irritation or dryness occurs, it is recommended that patients limit their use to one topical acne medication at a time to mitigate these effects.

In cases of accidental ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay. It is crucial to ensure that patients are aware of these precautions to promote safe and effective use of the medication.

Side Effects

Patients using this product should be aware that it is for external use only. The application of this medication may lead to skin irritation and dryness, particularly if used concurrently with another topical acne medication. In such cases, it is advised to limit the use to one topical acne treatment at a time to minimize the risk of adverse reactions.

In the event of accidental ingestion, patients are urged to seek medical assistance or contact a Poison Control Center immediately. This precaution is critical to ensure safety and appropriate management of any potential complications arising from ingestion.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate these effects, it is advised that only one topical acne medication be used at a time. This approach helps to minimize the potential for adverse skin reactions while ensuring the efficacy of the treatment. Monitoring for signs of irritation or dryness is recommended, and adjustments to the treatment regimen should be made accordingly.

Packaging & NDC

Below are the non-prescription pack sizes of Clinique Acne Solutions Cleansing Foam (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The product has not been specifically studied in pregnant patients, and there are no explicit warnings or precautions regarding its use during pregnancy in the available data. As such, the potential risks to fetal outcomes remain unclear. Healthcare professionals should consider the lack of data when prescribing this product to women of childbearing potential and weigh the benefits against any potential risks. It is advisable to monitor pregnant patients closely if the product is deemed necessary for use during pregnancy.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no information available regarding renal impairment, including dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of specific guidance when treating patients with renal impairment.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise caution and consider the lack of data when prescribing this medication to patients with liver problems.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical assistance or contact a Poison Control Center without delay.

Prompt action is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action and management procedures.

Healthcare providers should ensure that patients are aware of the importance of timely reporting of any suspected overdosage to facilitate effective treatment and minimize risks.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the medication is swallowed. It is crucial for patients to understand the potential risks associated with accidental ingestion and the importance of prompt action.

Additionally, healthcare providers should inform patients about the likelihood of skin irritation and dryness when using this medication in conjunction with other topical acne treatments. Patients should be counseled to use only one topical acne medication at a time to minimize the risk of adverse skin reactions. This guidance will help ensure the safe and effective use of the medication while reducing the potential for discomfort.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure to ensure optimal stability. Once opened, the product should be discarded to prevent any potential degradation or contamination.

Additional Clinical Information

The route of administration for the treatment is topical. Clinicians should advise patients that if bothersome drying or peeling occurs, they should reduce usage to every other day. It is recommended to start with one application daily to minimize excessive skin drying, with the option to gradually increase to twice a day if necessary or as directed by a healthcare provider. After the resolution of acne, patients are encouraged to continue using the treatment for preventative care.

Drug Information (PDF)

This file contains official product information for Clinique Acne Solutions Cleansing Foam, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)